A Word of Caution on Tapering Adalimumab and Managing Post-op CD

Miguel Regueiro, MD

Professor of Medicine
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland

For some people with Crohn’s disease, surgery is the only option that can provide substantial relief, so the fact that CD often returns postoperatively is distressing. In other patients, anti–tumor necrosis factor medications are working well, so well that we might consider extending the time between doses. This